University of Chicago Medicine — Chicago, Illinois

Public research footprint of University of Chicago Medicine, compiled from the ClinicalTrials.gov public registry.

394

Registered studies

217

Active

107

Recruiting now

119

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Fallopian Tube Carcinoma · Recurrent Primary Peritoneal Carcinoma · Recurrent Ovarian Carcinoma · Acute Myeloid Leukemia

Recently updated registry entries

NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)
NCT05554406 — Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed… (Recruiting)
NCT05256225 — Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Chicago Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.